Author of the publication

A predictive probability design for phase II cancer clinical trials.

, and . Clinical trials (London, England), 5 (2): 93-106 (January 2008)5653<m:linebreak></m:linebreak>GR: CA97007/CA/NCI NIH HHS/United States; JID: 101197451; 0 (Antineoplastic Agents); ppublish;<m:linebreak></m:linebreak>Fase II.
DOI: 10.1177/1740774508089279

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

BayesESS: A tool for quantifying the impact of parametric priors in Bayesian analysis., , , and . SoftwareX, (May 2023)A predictive probability design for phase II cancer clinical trials., and . Clinical trials (London, England), 5 (2): 93-106 (January 2008)5653<m:linebreak></m:linebreak>GR: CA97007/CA/NCI NIH HHS/United States; JID: 101197451; 0 (Antineoplastic Agents); ppublish;<m:linebreak></m:linebreak>Fase II.A better confidence interval for Kappa on measuring agreement between two raters with binary outcomes, and . Journal of Computational and Graphical Statistics, 3 (3): 301--321 (1994)Borrowing strength and borrowing index for Bayesian hierarchical models., , and . Comput. Stat. Data Anal., (2020)SwarmDeepSurv: swarm intelligence advances deep survival network for prognostic radiomics signatures in four solid cancers., , , , , , , , , and 4 other author(s). Patterns, 4 (8): 100777 (August 2023)Distillation Decision Tree., and . CoRR, (2022)drexplorer: A tool to explore dose-response relationships and drug-drug interactions., , , , , , , , and . Bioinform., 31 (10): 1692-1694 (2015)